Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT2 | P31751 | 4/20 | 0.44 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.44 |
| ▸ | AKT1 | P31749 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.38 |
| ▸ | SQOR | Q9Y6N5 | 1/20 | 0.38 |
| ▸ | JAK2 | O60674 | 1/20 | 0.38 |
| ▸ | JAK1 | P23458 | 1/20 | 0.38 |
| ▸ | TYK2 | P29597 | 1/20 | 0.38 |
| ▸ | JAK3 | P52333 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | METAP2 | P50579 | 1/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2419516 | 0.83 | MEN1 (0.40) | KMT2ALRRK2METAP2 | |
| SCHEMBL8809265 | 0.80 | SMN1; SMN2 (0.42) | AKT1HTTALDH1A1KMT2A | |
| SCHEMBL8360337 | 0.79 | DYRK1A (0.45) | ALOX15KMT2ALRRK2 | |
| SCHEMBL1978092 | 0.79 | SMN1; SMN2 (0.43) | AKT2AKT1HTTALDH1A1JAK2 | |
| SCHEMBL17785560 | 0.79 | KDR (0.39) | CHEK1L3MBTL1ALDH1A1JAK2METAP2 | |
| SCHEMBL24962591 | 0.79 | IKBKB (0.41) | KMT2AMETAP2 | |
| SCHEMBL1978865 | 0.79 | AKT2 (0.55) | AKT2L3MBTL1ALDH1A1KMT2A | |
| SCHEMBL8123127 | 0.77 | RXRA (0.44) | HTTALDH1A1KMT2APOLB | |
| SCHEMBL8123308 | 0.77 | MAP4K4 (0.45) | ALDH1A1METAP2 | |
| SCHEMBL16115039 | 0.77 | IKBKB (0.46) | HTTALDH1A1ALOX15KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210253871-A1 | CORROSION-RESISTANT CONDUCTIVE STRUCTURE AND CORROSION-RESISTANT COATING COMPOSITION | TPK UNIVERSAL SOLUTIONS LIMITED (HK) | 2021-08-19 | — | — | US | claimed |
| CN-111192857-A | Corrosion-resistant conductive structure and corrosion-resistant coating composition | 宸盛光电有限公司 | 2020-05-22 | — | — | CN | claimed |
| US-20190209441-A1 | GEL NETWORK HAIR TREATMENT COMPOSITIONS WITH REDUCED ODOR | WELLA OPERATIONS US, LLC | 2019-07-11 | — | — | US | claimed |
| US-20190192408-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | WELLA OPERATIONS US, LLC | 2019-06-27 | — | — | US | claimed |
| US-20190175476-A1 | HAIR COLORING OR BLEACHING COMPOSITION WITH REDUCED ODOR | WELLA OPERATIONS US, LLC | 2019-06-13 | — | — | US | claimed |
| US-20190155975-A9 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | THE PROCTER & GAMBLE COMPANY | 2019-05-23 | — | — | US | claimed |
| WO-2018053183-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | NOXELL CORPORATION (US) | 2018-03-22 | — | — | WO | claimed |
| WO-2018053065-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | THE PROCTER & GAMBLE COMPANY (US) | 2018-03-22 | — | — | WO | claimed |
| EP-3295925-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | Noxell Corporation (US) | 2018-03-21 | — | — | EP | claimed |
| WO-2018048933-A1 | HAIR COLORING OR BLEACHING COMPOSITION WITH REDUCED ODOR | NOXELL CORPORATION (US) | 2018-03-15 | — | — | WO | claimed |
| US-20160090555-A1 | CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| WO-2016049394-A1 | CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049455-A1 | PERSONAL CARE COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| US-20160031935-A1 | SMALL MOLECULE MODULATORS OF PCSK9 AND METHODS OF USE THEREOF | NUCHEM THERAPEUTICS (CA) | 2016-02-04 | — | — | US | claimed |
| EP-2961765-A1 | SMALL MOLECULE MODULATORS OF PCSK9 AND METHODS OF USE THEREOF | Adaerata, Limited Partnership (CA) | 2016-01-06 | — | — | EP | claimed |
| WO-2014139008-A1 | SMALL MOLECULE MODULATORS OF PCSK9 AND METHODS OF USE THEREOF | ADAERATA, LIMITED PARTNERSHIP (CA) | 2014-09-18 | — | — | WO | claimed |
| CN-101384240-A | Hair colouring compositions | PROCTER & GAMBLE (US) | 2009-03-11 | — | — | CN | claimed |
| WO-1998033786-A9 | ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS | — | 1998-12-30 | — | — | WO | claimed |
| WO-1998033786-A1 | ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-08-06 | — | — | WO | claimed |
| US-5468871-A | Catalytic N-alkylation | BASF AKTIENGESELLSCHAFT (DE) | 1995-11-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190192408-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | MAL2, MSH6, OR51E2 | AKT2 4680/4885CHEK1 2453/4885AKT1 4765/4885 |
| US-20160031935-A1 | SMALL MOLECULE MODULATORS OF PCSK9 AND METHODS OF USE THEREOF | PCSK9, PCSK7, PCSK6 | AKT2 870/4885CHEK1 3651/4885AKT1 681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.